The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s chemotherapy market report forecasts the chemotherapy market size to grow to $12.08 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Chemotherapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy Market Size Forecast
The global chemotherapy market is expected to grow from $8.22 billion in 2022 to $8.94 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global chemotherapy market size is expected to reach $12.08 billion in 2027 at a CAGR of 7.8%.

North America held the largest chemotherapy market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Chemotherapy Market Driver ­– Increase In The Cancer Prevalence
According to Globocan, a Swiss-based provider of a global database of cancer prevalence and mortality rates, there will be approximately 19.29 million new cancer cases worldwide in 2020, with the total number of cancer cases in 5 years predicted to reach 50.55 million. As a result, the growing cancer prevalence drives the chemotherapy market.

Request for A Sample Of The Global Chemotherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Key Chemotherapy Market Trend – Innovative Technology Development
To increase their market position, major firms in the chemotherapy market are focusing on developing innovative technical solutions such as using artificial intelligence and nanotechnology for real-time tracking and treatment. For example, ImpriMed, Inc., a US-based firm that delivers cutting-edge personalised treatment for dogs with blood cancer disorders, will unveil ” SDM4″, an AI-based chemotherapy prediction system for lymphoma, in October 2020. The technique is specifically intended for chemotherapy-sensitive assays using artificial intelligence (AI), which are optimised in just 7 days to provide improved sensitivity and specificity, as well as a high positive predictive value. This method assists in diagnosing the type of lymphoma cancer by taking a sample with fine needle aspiration.

Chemotherapy Market Segment
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users

Chemotherapy Market Major Players and Strategies
Major players in the chemotherapy market are GlaxoSmithKline PLC, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi S A, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology, Takeda Pharmaceutical Company Limited, and Johnson & Johnson Services Inc.

Amgen Inc., a worldwide biotechnology business based in the United States, paid $3.7 billion for ChemoCentryx Inc. in October 2021. Amgen’s inflammatory and nephrology portfolios are expected to benefit from the addition of ChemoCentryx’s TAVNEOS®. The companies are expected to work together to extend and innovate breakthrough treatments for patients suffering from critical ailments as a result of the acquisition. ChemoCentryx, Inc. is a biopharmaceutical business established in the United States that specialises in the treatment of autoimmune illnesses, inflammatory disorders, and cancer.

The Chemotherapy Global Market Report 2023 covers regional data on chemotherapy market size, chemotherapy market trends and drivers, opportunities, strategies, and chemotherapy market competitor analysis. The countries covered in the chemotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Chemotherapy is a treatment that employs pharmaceuticals or medicines that use powerful chemicals to kill rapidly growing cells in the body. The medications can be used alone or in combination to treat cancer. They are used to treat cancer because cancer cells grow quickly.

View More Reports Related To The Chemotherapy Market –
Antiemetics And Antinauseants Global Market Report 2023
Skin Cancer Drugs Global Market Report 2023
Prostate Cancer Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: